MagellanRx - Magellan Medicaid Administration on behalf of the TennCare Pharmacy Program

Author: Erica Lawrence/Wednesday, February 14, 2018/Categories: APCI Choice

Participation in the TennCare pharmacy program requires pharmacists to adhere to specific procedures when unresolved point-of sale denials are encountered. Denials for non-preferred medications, step therapy, therapeutic duplication, and quantity limits are subject to the following requirements of TennCare and federal regulations. The pharmacist must attempt to contact the prescriber and/or Magellan Clinical Support Call Center at 1-866-434-5524 to resolve the denial.

*Please see attached for more information.

Comments are only visible to subscribers.